PHOREMOST LIMITED
Get an alert when PHOREMOST LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2027-04-15 (in 11mo)
Last made up 2026-04-01
Watchouts
None on the register
Cash
£10M
+17.8% vs 2024
Net assets
£12M
+17.8% vs 2024
Employees
45
-6.3% vs 2024
Profit before tax
-£9M
+18.5% vs 2024
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2025-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Turnover | £1,047,683 | £1,567,820 | |
| Operating profit | -£11,864,233 | -£9,689,548 | |
| Profit before tax | -£11,593,922 | -£9,448,918 | |
| Net profit | -£9,914,629 | -£8,037,785 | |
| Cash | £8,833,348 | £10,406,050 | |
| Total assets less current liabilities | £12,613,888 | £13,488,038 | |
| Net assets | £9,962,892 | £11,736,843 | |
| Equity | £9,962,892 | £11,736,843 | |
| Average employees | 48 | 45 | |
| Wages | £3,536,043 | £3,480,909 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating margin | -1132.4% | -618.0% | |
| Net margin | -946.3% | -512.7% | |
| Return on capital employed | -94.1% | -71.8% | |
| Gearing (liabilities / total assets) | 33.7% | 24.7% | |
| Current ratio | 5.34x | 7.05x | |
| Interest cover | -91.19x | -83.81x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst and Young
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In August 2024, the Company raised £9.15 million in an extension to the March 2021 Series B funding round. The tranche payments were all received in 2024. The Company remains debt free. In June 2025, the company initiated a headcount reduction from 40 FTE to 22 FTE and focussed activity on a smaller number of very promising initiatives. The Directors have prepared forecasts covering the period from the date of signing these financial statements to 31 October 2026. Based on these forecasts, the Company expects to continue making losses as it invests further in research and development activities, however it is supported by the Company's existing available liquidity. Sensitivity analysis has been performed to reflect possible downside scenarios, including the impact of the current macro environment and delays in the timing of research and development activity. In each of these scenarios, the Company continues to have available liquidity. In a severe downside scenario, the Company also has further mitigating actions available which include deferring non-committed expenditure and reorganising staffing, which would further extend the available liquidity. Based on the above, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and meet its liabilities as they fall due for the period to 31 October 2026. The Directors therefore conclude that it is appropriate to prepare these financial statements on a going concern basis.”
Significant events
- “In August 2024, the company raised £9.15 million in a Series B extension to the previously raised £33 million Series B funding round in March 2021. This financing follows a £11 million Series A round in May 2018 and a £2 million Seed B round that was completed in February 2017.”
- “In June 2025, the company initiated a headcount reduction from 40 FTE to 22 FTE and focussed activity on a smaller number of very promising initiatives.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2015-12-17 | — | — |
| DILLY, Stephen George, Dr | Director | 2025-04-07 | May 1959 | British,American |
| DUNCAN, Barbara | Director | 2025-04-07 | Dec 1964 | American |
| REA, Timothy Shan | Director | 2021-03-22 | Mar 1967 | British |
| TORBETT, Neil Edward, Dr | Director | 2022-06-23 | Aug 1977 | British |
| TORRANCE, Christopher John, Dr | Director | 2014-04-01 | Feb 1969 | British |
| PARKWALK ADVISORS LTD | Corporate Director | 2019-04-17 | — | — |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| TORRANCE, Christopher John | Secretary | 2014-04-01 | 2024-09-17 |
| DINGES, Jason Robert, Dr | Director | 2023-01-26 | 2024-08-28 |
| HAUSER, Hermann Maria | Director | 2015-03-27 | 2024-08-28 |
| HUANG, Xiaolu | Director | 2022-12-01 | 2024-08-28 |
| JIANG, Yide Alan | Director | 2021-03-22 | 2022-11-15 |
| KILGOUR, Alastair Hugh Lowell | Director | 2018-05-01 | 2019-04-17 |
| MAYR, Lorenz Martin | Director | 2021-03-22 | 2024-05-08 |
| MILNER, Jonathan Simon, Dr | Director | 2024-04-09 | 2026-02-04 |
| MILNER, Jonathan Simon, Dr | Director | 2015-03-27 | 2023-05-08 |
| MINSHULL-BEECH, Catherine Susan, Dr | Director | 2021-03-22 | 2024-05-08 |
| PEGG, Neil Anthony, Dr | Director | 2021-03-22 | 2023-01-26 |
| VENKITARAMAN, Ashok, Professor | Director | 2014-04-01 | 2022-06-23 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Christopher John Torrance | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2017-02-23 |
| Professor Ashok Venkitaraman | Individual | Voting 25–50% | 2016-04-06 | Ceased 2017-02-23 |
Filing timeline
Last 20 of 105 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-09-09 MA Memorandum articles
- 2024-09-09 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-08 | AD01 | address | Change registered office address company with date old address new address | |
| 2026-04-20 | SH01 | capital | Capital allotment shares | |
| 2026-04-01 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-03-16 | SH01 | capital | Capital allotment shares | |
| 2026-02-13 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-03 | AA | accounts | Accounts with accounts type full | |
| 2025-04-25 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-25 | AP01 | officers | Appoint person director company with name date | |
| 2025-04-01 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-03-11 | SH01 | capital | Capital allotment shares | |
| 2024-09-26 | RP04AP01 | officers | Second filing of director appointment with name | |
| 2024-09-24 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-09-09 | MA | incorporation | Memorandum articles | |
| 2024-09-09 | RESOLUTIONS | resolution | Resolution | |
| 2024-09-05 | SH01 | capital | Capital allotment shares | |
| 2024-09-05 | SH01 | capital | Capital allotment shares | |
| 2024-09-03 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-03 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-03 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-02 | SH02 | capital | Capital alter shares subdivision |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 6
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
+49.6%
£1,047,683 £1,567,820
-
Cash
+17.8%
£8,833,348 £10,406,050
-
Net assets
+17.8%
£9,962,892 £11,736,843
-
Employees
-6.3%
48 45
-
Operating profit
+18.3%
-£11,864,233 -£9,689,548
-
Profit before tax
+18.5%
-£11,593,922 -£9,448,918
-
Wages
-1.6%
£3,536,043 £3,480,909
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers